NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
Related articles:
Related suggestion:
Chinese premier calls for better communication, exchanges among international communityXi extends congratulations to Yunnan University on centenary anniversaryFeature: Rafah drowning in tears as Palestinians bid farewell to loved ones for survivalPope Francis sides with Peruvian villagers who accused Catholic group of trying to steal their landXi urges modernization of industrial system, highReims and Rennes drop points in the French league chase for a European placeMiro Heiskanan, Jason Robertson lead Stars past Kraken 3People mourn for victims killed in Moscow terrorist attack in St. PetersburgHKSAR to hold 7th district council ordinary election on Dec. 10Search continues in Maine as officer is charged with lying about taking missing person to hospital
2.8826s , 6504.3828125 kb
Copyright © 2024 Powered by What do weight loss drugs mean for a diet industry built on eating less and exercising more? ,Global Glossary news portal